Dickson L - Search Results

1

VPAC and PAC receptors: From ligands to function.

Dickson L, Finlayson K. Dickson L, et al. Pharmacol Ther. 2009 Mar;121(3):294-316. doi: 10.1016/j.pharmthera.2008.11.006. Epub 2008 Dec 6. Pharmacol Ther. 2009. PMID: 19109992 Review.

2

VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways.

Dickson L, Aramori I, Sharkey J, Finlayson K. Dickson L, et al. Ann N Y Acad Sci. 2006 Jul;1070:239-42. doi: 10.1196/annals.1317.021. Ann N Y Acad Sci. 2006. PMID: 16888173

3

A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.

Dickson L, Aramori I, McCulloch J, Sharkey J, Finlayson K. Dickson L, et al. Neuropharmacology. 2006 Nov;51(6):1086-98. doi: 10.1016/j.neuropharm.2006.07.017. Epub 2006 Aug 23. Neuropharmacology. 2006. PMID: 16930633

4

5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail.

Barclay Z, Dickson L, Robertson DN, Johnson MS, Holland PJ, Rosie R, Sun L, Fleetwood-Walker S, Lutz EM, Mitchell R. Barclay Z, et al. Among authors: dickson l. Biochem J. 2011 Jun 15;436(3):651-60. doi: 10.1042/BJ20101844. Biochem J. 2011. PMID: 21410433

5

Attenuated PLD1 association and signalling at the H452Y polymorphic form of the 5-HT(2A) receptor.

Barclay Z, Dickson L, Robertson D, Johnson M, Holland P, Rosie R, Sun L, Jerina H, Lutz E, Fleetwood-Walker S, Mitchell R. Barclay Z, et al. Among authors: dickson l. Cell Signal. 2013 Apr;25(4):814-21. doi: 10.1016/j.cellsig.2013.01.004. Epub 2013 Jan 11. Cell Signal. 2013. PMID: 23314176

6

Identification of compounds acting as negative allosteric modulators of the LPA₁ receptor.

Ellery J, Dickson L, Cheung T, Ciuclan L, Bunyard P, Mack S, Buffham WJ, Farnaby W, Mitchell P, Brown D, Isaacs R, Barnes M. Ellery J, et al. Among authors: dickson l. Eur J Pharmacol. 2018 Aug 15;833:8-15. doi: 10.1016/j.ejphar.2018.05.040. Epub 2018 May 26. Eur J Pharmacol. 2018. PMID: 29807028

7

Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing.

Sakurai T, Davenport R, Stafford S, Grosse J, Ogawa K, Cameron J, Parton L, Sykes A, Mack S, Bousba S, Parmar A, Harrison D, Dickson L, Leveridge M, Matsui J, Barnes M. Sakurai T, et al. Among authors: dickson l. Eur J Pharmacol. 2014 Mar 15;727:1-7. doi: 10.1016/j.ejphar.2014.01.029. Epub 2014 Jan 30. Eur J Pharmacol. 2014. PMID: 24486398

8

Isolation and characterization of the human fibrillar collagen genes.

Ramirez F, Bernard M, Chu ML, Dickson L, Sangiorgi F, Weil D, De Wet W, Junien C, Sobel M. Ramirez F, et al. Among authors: dickson l. Ann N Y Acad Sci. 1985;460:117-29. doi: 10.1111/j.1749-6632.1985.tb51160.x. Ann N Y Acad Sci. 1985. PMID: 3868939

9

Analysis of the promoter region and the N-propeptide domain of the human pro alpha 2(I) collagen gene.

Dickson LA, de Wet W, Di Liberto M, Weil D, Ramirez F. Dickson LA, et al. Nucleic Acids Res. 1985 May 24;13(10):3427-38. doi: 10.1093/nar/13.10.3427. Nucleic Acids Res. 1985. PMID: 4011429 Free PMC article.

10

Organization of the human pro-alpha 2(I) collagen gene.

de Wet W, Bernard M, Benson-Chanda V, Chu ML, Dickson L, Weil D, Ramirez F. de Wet W, et al. Among authors: dickson l. J Biol Chem. 1987 Nov 25;262(33):16032-6. J Biol Chem. 1987. PMID: 2824475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results